Animol Discovery

About:

We are a biopharmaceutical company focused on identifying and developing next- generation antiparasitics and therapeutics.

Website: https://www.animol-discovery.com/

Top Investors: Finistere Ventures, Anterra Capital, Novalis LifeSciences

Description:

Animol is building its own pipeline of break-through proprietary veterinary small molecules led by a team of animal health industry experts with vast experience in bringing drugs to market. With our unique and powerful technology platform we deliver innovative medicines that are specifically designed for the needs of veterinary patients.

Total Funding Amount:

$49.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2019-01-01

Founders:

Philip Austin

Number of Employees:

11-50

Last Funding Date:

2023-04-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai